Infection Control News

A study of patients hospitalized with COVID-19 across the United States showed little difference in outcomes between solid organ transplant recipients and the general population.

Through its clinical research subsidiary, DaVita Inc. has begun enrolling participants for two trials designed to investigate the ways in which COVID-19 impacts patients with end-stage kidney disease who are currently receiving dialysis.

Among patients with COVID-19 treated at 13 New York hospitals, those with end-stage kidney disease had a higher rate of death compared with those without ESKD, according to a study published in Kidney International.

Type 1 diabetes does not increase risk for hospitalization from COVID-19, particularly among individuals without diabetes complications, according to an analysis of hospital data.

An analysis of patients who were hospitalized with COVID-19 in Belgium demonstrated SARS-CoV-2 caused specific manifestations of kidney proximal tubule dysfunction.

Baxter International Inc. has obtained two emergency use authorizations from the FDA for patients who may develop AKI during the COVID-19 pandemic.

Since the arrival of SARS-CoV-2 on U.S. shores, patients who receive dialysis for end-stage kidney disease have been at heightened risk. The first reported patient to die of COVID-19 was a 50-year-old man who received hemodialysis treatment at a Seattle-area dialysis facility.

Since the arrival of SARS-CoV-2 on U.S. shores, patients who receive dialysis for end-stage kidney disease have been at heightened risk. The first reported patient to die of COVID-19 was a 50-year-old man who received hemodialysis treatment at a Seattle-area dialysis facility.

The COVID-19 pandemic, which necessitated that greater numbers of patients receive dialysis at home, may give rise to continued increases in the utilization of such home-based therapies, according to two nephrology experts.

Patients with end-stage kidney disease and COVID-19 continued to be hospitalized at higher rates than other segments of the Medicare population also diagnosed with COVID-19, per the latest Medicare data.